Home » Analyst Articles – US

Earthstone Energy (ESTE) Raised to “Hold” at Zacks Investment Research

Earthstone Energy (ESTE) Raised to “Hold” at Zacks Investment Research

Earthstone Energy (NYSE:ESTE) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Wednesday. According to Zacks, “Earthstone Energy, Inc.,... 
Banco Macro (BMA) Lifted to Sell at ValuEngine

Banco Macro (BMA) Lifted to Sell at ValuEngine

Banco Macro (NYSE:BMA) was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a report issued on Wednesday. Several other equities analysts have also commented on BMA. Zacks... 
WEIR GRP PLC/S (WEGRY) Upgraded to “Hold” at ValuEngine

WEIR GRP PLC/S (WEGRY) Upgraded to “Hold” at ValuEngine

WEIR GRP PLC/S (OTCMKTS:WEGRY) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a report released on Wednesday. Separately, Zacks Investment Research downgraded WEIR... 
Emcor Group (EME) Raised to Hold at ValuEngine

Emcor Group (EME) Raised to Hold at ValuEngine

Emcor Group (NYSE:EME) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. EME has been the subject of several... 
Raymond James (RJF) Cut to Sell at ValuEngine

Raymond James (RJF) Cut to Sell at ValuEngine

Raymond James (NYSE:RJF) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday. Several other analysts have also weighed... 
Abercrombie & Fitch (ANF) Lowered to “Hold” at ValuEngine

Abercrombie & Fitch (ANF) Lowered to “Hold” at ValuEngine

Abercrombie & Fitch (NYSE:ANF) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Wednesday. Several other research analysts have also weighed in on ANF.... 
Centennial Resource Development (CDEV) Lifted to “Sell” at ValuEngine

Centennial Resource Development (CDEV) Lifted to “Sell” at ValuEngine

Centennial Resource Development (NASDAQ:CDEV) was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a report issued on Wednesday. Other equities research analysts have also... 
ValuEngine Lowers IBERIABANK (IBKC) to Sell

ValuEngine Lowers IBERIABANK (IBKC) to Sell

IBERIABANK (NASDAQ:IBKC) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Wednesday. Several other equities analysts also recently weighed in... 
SB One Bancorp (SBBX) Downgraded by ValuEngine to Strong Sell

SB One Bancorp (SBBX) Downgraded by ValuEngine to Strong Sell

SB One Bancorp (NASDAQ:SBBX) was downgraded by ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued on Wednesday. Other analysts have also issued research reports about the company.... 
CRODA INTL PLC/ADR (COIHY) Upgraded to Hold by Zacks Investment Research

CRODA INTL PLC/ADR (COIHY) Upgraded to Hold by Zacks Investment Research

CRODA INTL PLC/ADR (OTCMKTS:COIHY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. According to Zacks, “Croda... 
Acuity Brands (AYI) Rating Increased to Neutral at Goldman Sachs Group

Acuity Brands (AYI) Rating Increased to Neutral at Goldman Sachs Group

Acuity Brands (NYSE:AYI) was upgraded by research analysts at Goldman Sachs Group from a “sell” rating to a “neutral” rating in a research note issued on Wednesday, The Fly reports. Several other equities analysts... 
CRODA INTL PLC/ADR (COIHY) Upgraded to Hold by Zacks Investment Research

CRODA INTL PLC/ADR (COIHY) Upgraded to Hold by Zacks Investment Research

CRODA INTL PLC/ADR (OTCMKTS:COIHY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. According to Zacks, “Croda... 
Arrow Global Group (ARWGF) Raised to Hold at Zacks Investment Research

Arrow Global Group (ARWGF) Raised to Hold at Zacks Investment Research

Arrow Global Group (OTCMKTS:ARWGF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday. According to Zacks, “Arrow Global... 
Zacks Investment Research Downgrades Asure Software (ASUR) to Sell

Zacks Investment Research Downgrades Asure Software (ASUR) to Sell

Asure Software (NASDAQ:ASUR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Wednesday. According to Zacks, “Asure Software Inc., formerly Forgent... 
AeroCentury (ACY) Lifted to Buy at Zacks Investment Research

AeroCentury (ACY) Lifted to Buy at Zacks Investment Research

AeroCentury (NYSEAMERICAN:ACY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday. The firm presently has a $13.00 price target on the stock.... 
Zacks Investment Research Upgrades Western Digital (WDC) to “Hold”

Zacks Investment Research Upgrades Western Digital (WDC) to “Hold”

Western Digital (NASDAQ:WDC) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday. According to Zacks, “Western Digital is one... 
FUJIFILM Holdings Co. American Depositary Shares (FUJIY) Downgraded by Zacks Investment Research

FUJIFILM Holdings Co. American Depositary Shares (FUJIY) Downgraded by Zacks Investment Research

FUJIFILM Holdings Co. American Depositary Shares (OTCMKTS:FUJIY) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Wednesday.... 
Aurinia Pharmaceuticals (AUPH) Given New $11.00 Price Target at Raymond James

Aurinia Pharmaceuticals (AUPH) Given New $11.00 Price Target at Raymond James

Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its price objective boosted by investment analysts at Raymond James from $9.00 to $11.00 in a research report issued on Wednesday. The firm currently has an “outperform”... 
VIVENDI SA/ADR (VIVHY) Cut to Sell at Zacks Investment Research

VIVENDI SA/ADR (VIVHY) Cut to Sell at Zacks Investment Research

VIVENDI SA/ADR (OTCMKTS:VIVHY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday. According to Zacks, “Vivendi SA is a France-based... 
On Track Innovations (OTIV) Stock Rating Lowered by TheStreet

On Track Innovations (OTIV) Stock Rating Lowered by TheStreet

On Track Innovations (NASDAQ:OTIV) was downgraded by equities researchers at TheStreet from a “c-” rating to a “d” rating in a note issued to investors on Monday. Separately, Zacks Investment Research upgraded... 
Avis Budget Group (CAR) Stock Rating Lowered by Zacks Investment Research

Avis Budget Group (CAR) Stock Rating Lowered by Zacks Investment Research

Avis Budget Group (NASDAQ:CAR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday. According to Zacks, “Avis Budget is focused... 
Rite Aid (RAD) Upgraded by Zacks Investment Research to “Buy”

Rite Aid (RAD) Upgraded by Zacks Investment Research to “Buy”

Rite Aid (NYSE:RAD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday. The firm presently has a $0.75 price objective... 
Wedbush Reiterates Outperform Rating for resTORbio (TORC)

Wedbush Reiterates Outperform Rating for resTORbio (TORC)

resTORbio (NASDAQ:TORC)‘s stock had its “outperform” rating restated by research analysts at Wedbush in a research report issued on Monday. Wedbush also issued estimates for resTORbio’s FY2023 earnings at ($0.05)... 
Eiger Biopharmaceuticals (EIGR) Given a $43.00 Price Target at Wedbush

Eiger Biopharmaceuticals (EIGR) Given a $43.00 Price Target at Wedbush

Wedbush set a $43.00 target price on Eiger Biopharmaceuticals (NASDAQ:EIGR) in a research note published on Tuesday morning. The brokerage currently has a buy rating on the biotechnology company’s stock. Several other brokerages... 
Healthequity (HQY) Price Target Raised to $90.00 at Cantor Fitzgerald

Healthequity (HQY) Price Target Raised to $90.00 at Cantor Fitzgerald

Healthequity (NASDAQ:HQY) had its price target hoisted by equities research analysts at Cantor Fitzgerald from $83.00 to $90.00 in a research note issued to investors on Tuesday, The Fly reports. The brokerage currently has an “overweight”... 
MarketAxess (MKTX) Upgraded by Zacks Investment Research to “Buy”

MarketAxess (MKTX) Upgraded by Zacks Investment Research to “Buy”

Zacks Investment Research upgraded shares of MarketAxess (NASDAQ:MKTX) from a hold rating to a buy rating in a research note issued to investors on Tuesday morning. Zacks Investment Research currently has $261.00 price objective on... 
Miragen Therapeutics (MGEN) Upgraded to “Buy” by Zacks Investment Research

Miragen Therapeutics (MGEN) Upgraded to “Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of Miragen Therapeutics (NASDAQ:MGEN) from a hold rating to a buy rating in a report released on Tuesday. The brokerage currently has $3.25 target price on the medical research company’s... 
ImmunoGen (IMGN) Downgraded by JPMorgan Chase & Co.

ImmunoGen (IMGN) Downgraded by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered shares of ImmunoGen (NASDAQ:IMGN) from a neutral rating to an underweight rating in a report released on Tuesday, MarketBeat Ratings reports. A number of other brokerages also recently commented on... 
Irsa Inversiones y Rprsntcins (IRS) Downgraded by Zacks Investment Research to “Sell”

Irsa Inversiones y Rprsntcins (IRS) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research cut shares of Irsa Inversiones y Rprsntcins (NYSE:IRS) from a hold rating to a sell rating in a research report sent to investors on Tuesday. According to Zacks, “IRSA Inversiones y Representaciones... 
Lamb Weston (LW) Downgraded by Zacks Investment Research to Sell

Lamb Weston (LW) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research lowered shares of Lamb Weston (NYSE:LW) from a hold rating to a sell rating in a report issued on Tuesday. According to Zacks, “Lamb Weston’s shares have declined and underperformed the industry... 
Nike (NKE) Given a $85.00 Price Target by Goldman Sachs Group Analysts

Nike (NKE) Given a $85.00 Price Target by Goldman Sachs Group Analysts

Goldman Sachs Group set a $85.00 price objective on Nike (NYSE:NKE) in a research report released on Tuesday morning. The brokerage currently has a neutral rating on the footwear maker’s stock. A number of other equities research... 
Summit Materials (SUM) Stock Rating Upgraded by Zacks Investment Research

Summit Materials (SUM) Stock Rating Upgraded by Zacks Investment Research

Summit Materials (NYSE:SUM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Wednesday. The firm presently has a $20.00 price objective on the construction... 
Zacks Investment Research Downgrades RadNet (RDNT) to Hold

Zacks Investment Research Downgrades RadNet (RDNT) to Hold

Zacks Investment Research downgraded shares of RadNet (NASDAQ:RDNT) from a buy rating to a hold rating in a report published on Tuesday morning. According to Zacks, “RadNet, Inc., is a national market leader providing high-quality,... 
DEUTSCHE POST A/S (DPSGY) Upgraded by HSBC to “Buy”

DEUTSCHE POST A/S (DPSGY) Upgraded by HSBC to “Buy”

DEUTSCHE POST A/S (OTCMKTS:DPSGY) was upgraded by analysts at HSBC from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. DPSGY has been the topic of several other reports.... 
Goosehead Insurance (GSHD) Given a $32.00 Price Target at Keefe, Bruyette & Woods

Goosehead Insurance (GSHD) Given a $32.00 Price Target at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods set a $32.00 target price on Goosehead Insurance (NASDAQ:GSHD) in a research report report published on Tuesday. The brokerage currently has a hold rating on the stock. Separately, Zacks Investment Research... 
Rocket Pharmaceuticals (RCKT) Given a $39.00 Price Target at Oppenheimer

Rocket Pharmaceuticals (RCKT) Given a $39.00 Price Target at Oppenheimer

Oppenheimer set a $39.00 target price on Rocket Pharmaceuticals (NASDAQ:RCKT) in a report issued on Tuesday morning. The brokerage currently has a buy rating on the biotechnology company’s stock. A number of other research analysts... 
Mdu Resources Group (MDU) Earns “Buy” Rating from Williams Capital

Mdu Resources Group (MDU) Earns “Buy” Rating from Williams Capital

Williams Capital reissued their buy rating on shares of Mdu Resources Group (NYSE:MDU) in a report issued on Monday morning. Williams Capital also issued estimates for Mdu Resources Group’s FY2020 earnings at $1.63 EPS. Separately,... 
Shaw Communications (SJR) Raised to Buy at Zacks Investment Research

Shaw Communications (SJR) Raised to Buy at Zacks Investment Research

Shaw Communications (NYSE:SJR) (TSE:SJR.B) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Wednesday. The brokerage presently has a $23.00 price target... 
Cerner (CERN) Lowered to “Sell” at Zacks Investment Research

Cerner (CERN) Lowered to “Sell” at Zacks Investment Research

Cerner (NASDAQ:CERN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday. According to Zacks, “Cerner exited the fourth quarter on a mixed... 
Callon Petroleum (CPE) Downgraded by Capital One Financial to “Equal Weight”

Callon Petroleum (CPE) Downgraded by Capital One Financial to “Equal Weight”

Callon Petroleum (NYSE:CPE) was downgraded by equities research analysts at Capital One Financial from an “overweight” rating to an “equal weight” rating in a report issued on Wednesday, The Fly reports. A number... 
Cimarex Energy (XEC) Lowered to Equal Weight at Capital One Financial

Cimarex Energy (XEC) Lowered to Equal Weight at Capital One Financial

Cimarex Energy (NYSE:XEC) was downgraded by research analysts at Capital One Financial from an “overweight” rating to an “equal weight” rating in a report released on Wednesday. A number of other equities analysts... 
Splunk (SPLK) Given New $140.00 Price Target at Morgan Stanley

Splunk (SPLK) Given New $140.00 Price Target at Morgan Stanley

Splunk (NASDAQ:SPLK) had its price objective hoisted by research analysts at Morgan Stanley from $121.00 to $140.00 in a research note issued on Tuesday. The brokerage presently has an “equal weight” rating on the software... 
Tellurian (TELL) Upgraded to “Hold” by Zacks Investment Research

Tellurian (TELL) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Tellurian (NASDAQ:TELL) from a sell rating to a hold rating in a research note released on Tuesday morning. According to Zacks, “Tellurian Inc. develops low-cost liquefied natural... 
Urogen Pharma (URGN) Given Buy Rating at Oppenheimer

Urogen Pharma (URGN) Given Buy Rating at Oppenheimer

Oppenheimer reissued their buy rating on shares of Urogen Pharma (NASDAQ:URGN) in a report issued on Tuesday morning. A number of other equities research analysts also recently weighed in on URGN. HC Wainwright initiated coverage... 
American Tower (AMT) Price Target Raised to $208.00 at Bank of America

American Tower (AMT) Price Target Raised to $208.00 at Bank of America

American Tower (NYSE:AMT) had its price objective boosted by Bank of America from $172.00 to $208.00 in a report issued on Tuesday morning. Bank of America currently has a buy rating on the real estate investment trust’s stock. Other... 
Viper Energy Partners (VNOM) Lowered to “Hold” at BidaskClub

Viper Energy Partners (VNOM) Lowered to “Hold” at BidaskClub

BidaskClub cut shares of Viper Energy Partners (NASDAQ:VNOM) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning. Other equities research analysts have also issued research reports about the... 
Comerica (CMA) Downgraded by Zacks Investment Research to Hold

Comerica (CMA) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research lowered shares of Comerica (NYSE:CMA) from a buy rating to a hold rating in a research report report published on Tuesday morning. According to Zacks, “Shares of Comerica have outperformed the industry... 
Becton Dickinson and (BDX) Price Target Lowered to $280.00 at Raymond James

Becton Dickinson and (BDX) Price Target Lowered to $280.00 at Raymond James

Becton Dickinson and (NYSE:BDX) had its price objective decreased by Raymond James from $290.00 to $280.00 in a research note released on Tuesday. Raymond James currently has a strong-buy rating on the medical instruments supplier’s... 
BidaskClub Downgrades Empire Resorts (NYNY) to Sell

BidaskClub Downgrades Empire Resorts (NYNY) to Sell

BidaskClub cut shares of Empire Resorts (NASDAQ:NYNY) from a hold rating to a sell rating in a report issued on Tuesday morning. Shares of Empire Resorts stock opened at $10.51 on Tuesday. The company has a debt-to-equity ratio of... 
Cimpress (CMPR) Given a $100.00 Price Target by Barrington Research Analysts

Cimpress (CMPR) Given a $100.00 Price Target by Barrington Research Analysts

Barrington Research set a $100.00 target price on Cimpress (NASDAQ:CMPR) in a research report sent to investors on Tuesday. The brokerage currently has a buy rating on the business services provider’s stock. A number of other...